MEDIPOST's investigational therapy is an umbilical cord blood-derived allogeneic mesenchymal stem cell therapy designed to treat symptomatic cartilage defects in patients with knee osteoarthritis.

Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a promising disease-modifying agent in rheumatoid arthritis (RA), because of its ...

An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.

A painful knee or a stiff shoulder can signal age-related wear and tear, osteoarthritis, or even an autoimmune disease. But ...

Following Mesoblast's breakthrough FDA approval for its stem-cell therapy, activity in the sector has burgeoned. Investors – stay tuned!

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that ...

Infrapatellar fat pad glucocorticoid injections failed to show significant improvements in joint effusion or pain in knee osteoarthritis.

Osteoarthritis is increasingly diagnosed in younger, active people. Early detection could be key to reducing pain and ...

The condition mainly affects the knees, hips, hands, and spine, making everyday activities such as walking, standing, or ...

New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken ...

But not anymore — Ferree was one of the first patients to get a new implant with Dr. Richard Tosti at Rothman Orthopaedics.

Compared with sham treatment, genicular nerve radiofrequency ablation provides superior and durable relief for chronic knee pain.